Literature DB >> 24057454

Schizophrenia-like phenotype of polysialyltransferase ST8SIA2-deficient mice.

Tim Kröcher1, Kristina Malinovskaja, Monika Jürgenson, Anu Aonurm-Helm, Tamara Zharkovskaya, Anti Kalda, Iris Röckle, Miriam Schiff, Birgit Weinhold, Rita Gerardy-Schahn, Herbert Hildebrandt, Alexander Zharkovsky.   

Abstract

Posttranslational modification of the neural cell adhesion molecule (NCAM) by polysialic acid (polySia) is crucial for nervous system development and brain plasticity. PolySia attachment is catalyzed by the polysialyltransferases (polySTs) ST8SIA2 and ST8SIA4, two enzymes with distinct but also common functions during neurodevelopment and in the adult brain. A growing body of evidence links aberrant levels of NCAM and polySia as well as variation in the ST8SIA2 gene to neuropsychiatric disorders, including schizophrenia. To investigate whether polyST deficiency might cause a schizophrenia-like phenotype, St8sia2 (-/-) mice, St8sia4 (-/-) mice and their wildtype littermates were assessed neuroanatomically and subjected to tests of cognition and sensorimotor functions. St8sia2 (-/-) but not St8sia4 (-/-) mice displayed enlarged lateral ventricles and a size reduction of the thalamus accompanied by a smaller internal capsule and a highly disorganized pattern of fibers connecting thalamus and cortex. Reduced levels of the vesicular glutamate transporter VGLUT2 pointed towards compromised glutamatergic thalamocortical input into the frontal cortex of St8sia2 (-/-) mice. Both polyST-deficient lines were impaired in short- and long-term recognition memory, but only St8sia2 (-/-) mice displayed impaired working memory and deficits in prepulse inhibition. Furthermore, only the St8sia2 (-/-) mice exhibited anhedonic behavior and increased sensitivity to amphetamine-induced hyperlocomotion. These results reveal that reduced polysialylation in St8sia2 (-/-) mice leads to pathological brain development and schizophrenia-like behavior. We therefore propose that genetic variation in ST8SIA2 has the potential to confer a neurodevelopmental predisposition to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24057454     DOI: 10.1007/s00429-013-0638-z

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  20 in total

1.  Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases.

Authors:  Matthew S Macauley; Britni M Arlian; Cory D Rillahan; Poh-Choo Pang; Nikki Bortell; Maria Cecilia G Marcondes; Stuart M Haslam; Anne Dell; James C Paulson
Journal:  J Biol Chem       Date:  2014-11-03       Impact factor: 5.157

Review 2.  Mental disorders and an acidic glycan-from the perspective of polysialic acid (PSA/polySia) and the synthesizing enzyme, ST8SIA2.

Authors:  Chihiro Sato; Masaya Hane
Journal:  Glycoconj J       Date:  2018-07-30       Impact factor: 2.916

3.  Developmental Regulation of Basket Interneuron Synapses and Behavior through NCAM in Mouse Prefrontal Cortex.

Authors:  Chelsea S Sullivan; Vishwa Mohan; Paul B Manis; Sheryl S Moy; Young Truong; Bryce W Duncan; Patricia F Maness
Journal:  Cereb Cortex       Date:  2020-06-30       Impact factor: 5.357

Review 4.  Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration.

Authors:  Ronald L Schnaar; Rita Gerardy-Schahn; Herbert Hildebrandt
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

5.  Characterisation of genetic variation in ST8SIA2 and its interaction region in NCAM1 in patients with bipolar disorder.

Authors:  Alex D Shaw; Yash Tiwari; Warren Kaplan; Anna Heath; Philip B Mitchell; Peter R Schofield; Janice M Fullerton
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

6.  Brain structure, cognition and negative symptoms in schizophrenia are associated with serum levels of polysialic acid-modified NCAM.

Authors:  F Piras; M Schiff; C Chiapponi; P Bossù; M Mühlenhoff; C Caltagirone; R Gerardy-Schahn; H Hildebrandt; G Spalletta
Journal:  Transl Psychiatry       Date:  2015-10-13       Impact factor: 6.222

7.  ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons.

Authors:  Lukasz Mateusz Szewczyk; Nikola Brozko; Andrzej Nagalski; Iris Röckle; Sebastian Werneburg; Herbert Hildebrandt; Marta Barbara Wisniewska; Jacek Kuznicki
Journal:  Glia       Date:  2016-08-18       Impact factor: 7.452

8.  Chlorpromazine Increases the Expression of Polysialic Acid (PolySia) in Human Neuroblastoma Cells and Mouse Prefrontal Cortex.

Authors:  Chikara Abe; Saki Nishimura; Airi Mori; Yuki Niimi; Yi Yang; Masaya Hane; Ken Kitajima; Chihiro Sato
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

9.  Differential effect of disease-associated ST8SIA2 haplotype on cerebral white matter diffusion properties in schizophrenia and healthy controls.

Authors:  Janice M Fullerton; Paul Klauser; Rhoshel K Lenroot; Alex D Shaw; Bronwyn Overs; Anna Heath; Murray J Cairns; Joshua Atkins; Rodney Scott; Peter R Schofield; Cyndi Shannon Weickert; Christos Pantelis; Alex Fornito; Thomas J Whitford; Thomas W Weickert; Andrew Zalesky
Journal:  Transl Psychiatry       Date:  2018-01-22       Impact factor: 6.222

10.  Amygdala GluN2B-NMDAR dysfunction is critical in abnormal aggression of neurodevelopmental origin induced by St8sia2 deficiency.

Authors:  Alexandre Bacq; Simone Astori; Elias Gebara; Wei Tang; Bianca A Silva; Jose Sanchez-Mut; Jocelyn Grosse; Isabelle Guillot de Suduiraut; Olivia Zanoletti; Catherine Maclachlan; Graham W Knott; Johannes Gräff; Carmen Sandi
Journal:  Mol Psychiatry       Date:  2018-08-08       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.